New Jersey SR 38: Urges NJ DOH to increase public awareness on effects of xylazine.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: SR 38

Sponsors: Polistina, Vincent J., Steinhardt, Douglas J.

View New Jersey SR 38 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.